There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Veru (VERU – Research Report), Otonomy (OTIC – Research Report) and Karuna Therapeutics (KRTX – Research Report) with bullish sentiments.
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Veru today and set a price target of $24.00. The company’s shares closed last Monday at $13.31.
According to TipRanks.com, Chen is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Veru with a $30.33 average price target, a 108.2% upside from current levels. In a report issued on July 11, Oppenheimer also reiterated a Buy rating on the stock with a $36.00 price target.
In a report released today, Oren Livnat from H.C. Wainwright reiterated a Buy rating on Otonomy, with a price target of $5.50. The company’s shares closed last Monday at $1.95.
According to TipRanks.com, Livnat is a 1-star analyst with an average return of
Currently, the analyst consensus on Otonomy is a Moderate Buy with an average price target of $5.50.
Karuna Therapeutics (KRTX)
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Karuna Therapeutics, with a price target of $160.00. The company’s shares closed last Monday at $127.92.
According to TipRanks.com, Selvaraju is ranked 0 out of 5 stars with an average return of
Karuna Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $177.13, representing a 37.7% upside. In a report issued on July 14, SVB Securities also initiated coverage with a Buy rating on the stock with a $170.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on VERU:
- Needham Thinks Universal Display’s Stock is Going to Recover
- NXP Semiconductors (NXPI) Receives a Buy from Needham
- Berenberg Bank Maintains a Hold Rating on Swiss Re AG (SSREF)
- Analysts Offer Insights on Technology Companies: Calix (CALX) and Dynatrace (DT)
- NIO Needs More Than Rising Sales to Win Investors’ Trust